Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
Clinical trial NCT06698692 · RECRUITING
Trial details
- NCT number
- NCT06698692
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-02
- Primary completion
- 2024-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.